FY2027-Q1 revenue recovered to ¥245.984 million on increased seed crystal shipments, but progress toward the full-year revenue forecast of ¥1,100 million was only 22.4%. The operating loss of ¥227.473 million had already reached 80.4% of the full-year forecast loss of ¥283 million. In FY2027-H1, it will be necessary to confirm both continued shipments and a reduction in losses.
All recorded disclosures and news since the latest annual or semiannual filing. Switching watchpoints keeps the full history. Select an item to inspect its source.2026-06-24 〜 2026-11-06 · 29 of 29 items
Scroll the timeline →
Whether cumulative FY2027-H1 revenue will exceed ¥550 million, the mechanical 50% benchmark against the ¥1,100 million full-year forecast
Whether the cumulative H1 operating loss will narrow from the Q1 operating loss of ¥227 million
Whether the full-year forecasts of an operating loss of ¥283 million, an ordinary loss of ¥189 million and a net loss of ¥195 million will be maintained
Whether product-level revenue will confirm that seed crystal shipments, the main driver of Q1 revenue, continued in Q2
FY2026 ended on a difficult note, with revenue of ¥516.552 million, an operating loss of ¥1,360.496 million, an ordinary loss of ¥1,341.129 million and a net loss attributable to owners of the parent of ¥2,415.745 million. In contrast, FY2027-Q1 revenue was ¥245.984 million, the operating loss was ¥227.473 million, the ordinary loss was ¥237.337 million and the quarterly net loss attributable to owners of the parent was ¥238.610 million. Revenue rose 666.2% year on year, while each loss narrowed from the year-earlier period. The recovery began as shipments progressed against seed crystal orders secured in the fourth quarter of FY2026.
However, revenue of ¥245.984 million represents only 22.4% of the ¥1,100 million full-year forecast. Meeting the full-year forecast requires adding ¥854.016 million in revenue from Q2 through Q4, meaning that revenue approximately 3.5 times Q1's level must be generated over the remaining 3 quarters. The simple benchmark for half-year progress is ¥550 million. If FY2027-H1 falls below this level, shipments will need to be concentrated even more heavily in the second half.
On the earnings side, the operating loss was already ¥227.473 million in Q1, compared with a full-year operating loss forecast of ¥283 million. On a simple calculation, the full-year forecast will be difficult to achieve unless the combined operating loss from Q2 onward is kept within ¥55.527 million or an operating profit is generated in the latter part of the year. In FY2026, cash flow from operating activities was also negative ¥968 million, so an improvement in the earnings structure, including fixed costs, outsourcing costs and research and development expenses, will be needed rather than a simple recovery in revenue.
At the next results announcement, Q2 standalone and H1 cumulative revenue and operating results should be reviewed separately. In particular, it will be important to determine whether Q1 seed crystal revenue of ¥206 million represented shipments against a temporary backlog or whether shipments continued at a similar level in Q2. Whether the full-year outlook, including the ¥1,100 million revenue forecast and ¥283 million operating loss forecast, is maintained or revised again will also help assess the credibility of the recovery scenario.
Product mix as a percentage of the FY2027 revenue forecast (%)
Select a value or step to inspect its source.
Ordered by date. Disclosures and financial records differ from news and company threads; open each source to inspect it.
2026-11-12 · Awaiting publication
· Awaiting publication
The prior-year comparison for this event
2025-11-12 disclosed · In ¥ millions; each quarter is cumulative from the start of the fiscal year. EPS is in yen.
Latest available: FY2027 Q1
Net salesBusiness scale
137JPY m
↘ -68.6% YoYOperating profitCore earnings
-507JPY m
YoY unavailableNewest first. The highlighted column is this event’s comparison. YoY uses the same period and accounting basis.
| Metric | FY2027 Q1 | FY2026 full year | FY2026 Q3 | FY2026 Q2Comparison | FY2026 Q1 | FY2025 full year | FY2025 Q3 | FY2025 Q2 |
|---|---|---|---|---|---|---|---|---|
| Net sales | 245↗ +665.6% YoY | 516↘ -42.8% YoY | 253↘ -61.3% YoY | 137↘ -68.6% YoY | 32YoY unavailable | 902YoY unavailable | 654YoY unavailable | 436YoY unavailable |
| Operating profit | -227YoY unavailable | -1,360YoY unavailable | -954YoY unavailable | -507YoY unavailable | -263YoY unavailable | -976YoY unavailable | -741YoY unavailable | -546YoY unavailable |
| Ordinary profit | -237YoY unavailable | -1,341YoY unavailable | -942YoY unavailable | -501YoY unavailable | -275YoY unavailable | -989YoY unavailable | -722YoY unavailable | -572YoY unavailable |
| Net income | -238YoY unavailable | -2,415YoY unavailable | -2,011YoY unavailable | -504YoY unavailable | -276YoY unavailable | -2,306YoY unavailable | -725YoY unavailable | -576YoY unavailable |
| Earnings per share | -15.31YoY unavailable | -164.94YoY unavailable | -138.94YoY unavailable | -34.9YoY unavailable | -19.15YoY unavailable | -171.38YoY unavailable | -54.64YoY unavailable | -43.79YoY unavailable |